Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1. |
In vitro | CMLD010509 is a potent and selective translation inhibitor through an eIF4E phosphorylation-independent mechanism. CMLD010509 shows an IC50 below 10 nM for most MM cell lines and induces apoptosis. |
Synonyms | SDS-1-021 |
Molecular Weight | 556.4 |
Formula | C27H26BrNO7 |
CAS No. | 256497-58-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CMLD010509 256497-58-2 Others CMLD-010509 SDS-1-021 CMLD 010509 inhibitor inhibit